Sequent Scien.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE807F01027
  • NSEID: SEQUENT
  • BSEID: 512529
INR
200.10
-7.55 (-3.64%)
BSENSE

Dec 05

BSE+NSE Vol: 17.02 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,551.37
1,369.73
1,420.91
1,412.82
1,361.62
1,179.24
1,039.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,551.37
1,369.73
1,420.91
1,412.82
1,361.62
1,179.24
1,039.31
Raw Material Cost
617.37
613.67
693.10
670.52
588.67
511.70
453.87
Purchase of Finished goods
212.57
175.54
121.77
171.89
145.02
88.89
116.64
(Increase) / Decrease In Stocks
-18.09
-29.46
18.90
-49.42
-39.03
4.46
-27.50
Employee Cost
281.12
250.57
258.39
231.37
187.22
165.06
145.95
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.99
0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
296.61
298.00
315.81
279.05
267.66
238.81
225.41
Total Expenditure (Excl Depreciation)
1,389.58
1,308.32
1,408.96
1,303.42
1,149.54
1,008.92
914.37
Operating Profit (PBDIT) excl Other Income
161.79
61.41
11.95
109.40
212.08
170.32
124.94
Other Income
14.69
10.96
6.39
10.85
8.36
10.09
8.67
Operating Profit (PBDIT)
176.48
72.37
18.34
120.25
220.44
180.41
133.61
Interest
60.75
48.09
35.52
15.77
24.38
35.71
32.80
Exceptional Items
-4.97
-17.39
-64.79
0.00
-8.82
0.00
0.00
Gross Profit (PBDT)
110.76
6.89
-81.97
104.48
187.24
144.70
100.81
Depreciation
66.45
61.54
55.69
51.54
50.60
50.62
41.92
Profit Before Tax
44.31
-54.65
-137.66
52.93
136.63
94.08
58.88
Tax
12.05
-25.03
-15.68
8.17
32.18
12.03
2.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
32.26
-29.62
-121.98
44.76
104.45
82.05
56.88
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
32.26
-29.62
-121.98
44.76
104.45
82.05
56.88
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.38
-6.26
0.82
-3.81
-9.01
-12.14
-8.22
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.88
-35.88
-121.16
40.96
95.44
69.91
48.66
Equity Capital
50.06
49.89
49.89
49.67
49.67
49.67
49.37
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
654.41
606.67
648.89
642.73
677.98
637.43
657.32
Earnings per share (EPS)
0.87
-1.44
-4.86
1.65
3.84
2.81
1.97
Diluted Earnings per share
0.85
-1.44
-4.88
1.63
3.85
2.85
1.99
Operating Profit Margin (Excl OI)
10.43%
4.48%
0.84%
7.74%
15.58%
14.44%
12.02%
Gross Profit Margin
7.14%
0.5%
-5.77%
7.4%
13.75%
12.27%
9.7%
PAT Margin
2.08%
-2.16%
-8.58%
3.17%
7.67%
6.96%
5.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 13.26% vs -3.60% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 160.98% vs 70.39% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 163.46% vs 413.89% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.33% vs 35.39% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Sequent Scien. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,551.37
0
1,551.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,551.37
0
1,551.37
Raw Material Cost
617.37
0
617.37
Purchase of Finished goods
212.57
0
212.57
(Increase) / Decrease In Stocks
-18.09
0
-18.09
Employee Cost
281.12
0
281.12
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
296.61
0.00
296.61
Total Expenditure (Excl Depreciation)
1,389.58
0
1,389.58
Operating Profit (PBDIT) excl Other Income
161.79
0.00
161.79
Other Income
14.69
0
14.69
Operating Profit (PBDIT)
176.48
0
176.48
Interest
60.75
0
60.75
Exceptional Items
-4.97
0
-4.97
Gross Profit (PBDT)
110.76
0
110.76
Depreciation
66.45
0
66.45
Profit Before Tax
44.31
0
44.31
Tax
12.05
0
12.05
Provisions and contingencies
0.00
0
0.00
Profit After Tax
32.26
0
32.26
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
32.26
0
32.26
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-10.38
0
-10.38
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.88
0
21.88
Equity Capital
50.06
0
50.06
Face Value
2.00
0
0.00
Reserves
654.41
0
654.41
Earnings per share (EPS)
0.87
0
0.87
Diluted Earnings per share
0.85
0
0.85
Operating Profit Margin (Excl OI)
10.43%
0%
0.00
10.43%
Gross Profit Margin
7.14%
0%
0.00
7.14%
PAT Margin
2.08%
0%
0.00
2.08%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,551.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.26% vs -3.60% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 21.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 160.98% vs 70.39% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 161.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 163.46% vs 413.89% in Mar 2024

Annual - Interest
Interest 60.75 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.33% vs 35.39% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.43%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024